Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Neoplasms 3Breast Neoplasms 2Tongue Neoplasms 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Neutropenia 1Lymphedema 1Head and Neck Neoplasms 1Genital Neoplasms, Female 1Esthesioneuroblastoma, Olfactory 1Colorectal Neoplasms 1Breast Neoplasms, Male 1Anemia 1

Interventions

pegfilgrastim 30Filgrastim 29Cyclophosphamide 10pegylated granulocyte colony-stimulating factor 8Docetaxel 8Etoposide 7Cytarabine 7Ciprofloxacin 6Cefepime 6Vancomycin 5Leucovorin 5Fluorouracil 5eflapegrastim 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Methotrexate 3Levofloxacin 3Irinotecan 3Idarubicin 3Daunorubicin 3Cyclosporine 3Caspofungin 3Carboplatin 3Amikacin 3trifluridine tipiracil drug combination 2plerixafor 2liposomal amphotericin B 2Vincristine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Moxibustion × Clear all
NCT02781155 2016-05-24

Limiting Chemotherapy Side Effects by Using Moxa

East and North Hertfordshire NHS Trust

Phase 1/2 Unknown
25 enrolled
BreastClassical hematologyGastrointestinal

Anemia, Breast Neoplasms, Genital Neoplasms, Female, Neoplasms, Neutropenia, Thrombocytopenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡